Case File
efta-01790885DOJ Data Set 10OtherEFTA01790885
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01790885
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Giuffrida, David J
Sent:
Tuesday, January 25, 2011 10:23 PM
To:
Epstein, Jeffrey ([email protected])
Cc:
Barrett, Paul S
Subject:
AAPL trade details
Jeffrey,
You bought 8,860 AAPL @ $339.4=/share [$3,007,792.80]
<=o:p>
Let me know if you have any questions.
Thanks again. =/span>
David J. Giuffrida
J.P. Morgan I Global Invest=ent Opportunities Group
40 =est 57th Street,
N=w York, NY 10019
IRS Circular 230 Disclosure: =/span>
JPMorgan Chase & Co. and its affiliates do not provide=tax advice. Accordingly, any discussion of U.S. tax=/span>
matters contained herein (including any attachments) is not =ntended or written to be used, and cannot be used, in
connection with the =romotion, marketing or recommendation by anyone unaffiliated with JPMorgan=Chase & Co. of
any of the matters addressed herein or for the purpos= of avoiding U.S. tax-related penalties.<=span>
=/o:p>
EFTA_R1_00120334
EFTA01790885
This communication is for informational purposes=only. It is not intended as an offer or solicitation for the purchase
or=sale of any financial instrument or as an official confirmation of any tra=saction. All market prices, data and other
information are not warranted=as to completeness or accuracy and are subject to change without notice.=Any
comments or statements made herein do not necessarily reflect those of=1PMorgan Chase & Co., its subsidiaries and
affiliates. This=transmission may contain information that is privileged, confidential, leg=lly privileged, and/or exempt
from disclosure under applicable law. If y=u are not the intended recipient, you are hereby notified that any disclos=re,
copying, distribution, or use of the information contained herein (inc=uding any reliance thereon) is STRICTLY
PROHIBITED. Although this transm=ssion and any attachments are believed to be free of any virus or other de=ect that
might affect any computer system into which it is received and op=ned, it is the responsibility of the recipient to ensure
that it is virus =ree and no responsibility is accepted by WMorgan Chase & Co., its subsi=iaries and affiliates, as
applicable, for any loss or damage arising in an= way from its use. If you received this transmission in error, please
im=ediately contact the sender and destroy the material in its entirety, whet=er in electronic or hard copy format. Thank
you. Please ref=r to http://www.jpmorgan.com/pages/disclosures for disclosures relatin= to European legal entities.
2
EFTA_R1_00120335
EFTA01790886
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]URL
http://www.jpmorgan.com/pages/disclosuresRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.